Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
The approval expands treatment options across the EU, with broader market rollout planned in the second half of 2026
Identifying what foods cause kidney stones helps set simple, durable diet changes
The Gastrointestinal Safety of Orforglipron, a GLP-1 Receptor Agonist: A Network Meta-Analysis of Randomized Controlled Trials
Feb 24: This past weekend brought bad news for Oncopeptides as the FDA announced it would withdraw the approval of Pepaxto, which was greenlit in March 2021, in combination with dexamethasone, to treat certain patients with multiple myeloma
US$ 20.97
/assets/images/provider/photos/2749086.jpeg)
US$ 20.75
US$ 29.50
US$ 25.26
